MAQUET is a subsidiary of the publicly-listed Swedish group of companies GETINGE AB. The MAQUET brand represents the Medical Systems business division. Together with the two other business areas ARJO Extended Care and GETINGE Infection Control, the entire GETINGE group of companies focuses on forward-looking medical technology. For the fiscal year 2005 the GETINGE Group posted sales revenues of 1,280 billion euros with a workforce of approximately 7,400 employees. Worldwide MAQUET ranks among the leading providers of medical technology for emergency rooms, operating rooms and intensive care units. Since its foundation more than 165 years ago, MAQUET has stood for innovation and technological progress in the field of medicine.
The Impella percutaneous left ventricular assist devices (pLVAD) is an emerging option for partial or total circulatory support. In several randomized, controlled trials, pLVAD therapy demonstrated a better hemodynamic profile compared to IABP, although this did not translate into improved 30-day survival with use of pLVAD therapy.